Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Other Non-Current Liabilities (2021 - 2023)

Historic Other Non-Current Liabilities for Inmune Bio (INMB) over the last 3 years, with Q3 2023 value amounting to $804000.0.

  • Inmune Bio's Other Non-Current Liabilities changed N/A to $804000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $804000.0, marking a year-over-year change of. This contributed to the annual value of $550000.0 for FY2022, which is N/A changed from last year.
  • As of Q3 2023, Inmune Bio's Other Non-Current Liabilities stood at $804000.0.
  • In the past 5 years, Inmune Bio's Other Non-Current Liabilities ranged from a high of $804000.0 in Q3 2023 and a low of $160000.0 during Q2 2021
  • In the last 3 years, Inmune Bio's Other Non-Current Liabilities had a median value of $397000.0 in 2021 and averaged $439500.0.